Groundbreaking £21.9M UK Platform Launched to Advance Cancer Immunotherapy
Cancer immunotherapy represents a remarkable advancement in medical science, offering hope for conditions once considered untreatable. While some patients experience life-changing results, a large number face limited success or significant side effects. This is particularly evident with melanoma treatments, where fewer than half of patients benefit from immunotherapy.
